Ocular Therapeutix, Inc. (NASDAQ:OCUL – Free Report) – Equities researchers at William Blair upped their FY2025 EPS estimates for shares of Ocular Therapeutix in a note issued to investors on Wednesday, October 1st. Get Ocular Therapeutix alerts:Ocular Therapeutix (NASDAQ:OCUL – Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. Ocular Therapeutix had a negative net margin of 382.51% and a negative return on equity of 71.92%. View Our Latest Research Report on Ocular TherapeutixOcular Therapeutix Trading Up 3.2%Shares of Ocular Therapeutix stock opened at $11.41 on Friday. See AlsoReceive News & Ratings for Ocular Therapeutix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ocular Therapeutix and related companies with MarketBeat.com's FREE daily email newsletter.